| Features: |
| Dipyridamole is a medication primarily used for its antiplatelet and vasodilatory effects.
Dipyridamole is primarily known as a phosphodiesterase inhibitor and anti‐platelet agent. Mechanism: Dipyridamole inhibits phosphodiesterases (PDEs), enzymes that break down cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Cancer Relevance: Increased cyclic nucleotide levels can affect cell proliferation, apoptosis, and differentiation. Elevated cAMP, for example, may contribute to growth arrest or modify signaling cascades in certain cancer cells. • Dipyridamole has been observed in some studies to exert antioxidant effects. • There is evidence—albeit less definitive in some cases—that dipyridamole might influence mitochondrial function, potentially altering the balance between ROS production and detoxification. • By stabilizing mitochondrial membranes or affecting mitochondrial signaling pathways, dipyridamole could reduce the likelihood of excessive ROS generation. Current literature does not provide strong evidence that dipyridamole directly inhibits the mevalonate pathway?? |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:293 Target#:% State#:% Dir#:%
wNotes=on sortOrder:rid,rpid